How I treat cobalamin (vitamin B12) deficiency

被引:210
作者
Carmel, Ralph [1 ,2 ]
机构
[1] New York Methodist Hosp, Dept Med, Brooklyn, NY 11215 USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1182/blood-2008-03-040253
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The challenges in medical management of cobalamin deficiency lie in attention to the unique pathophysiology that underlies cobalamin deficiency, more than in the mechanics of therapy. The central physiologic principles are that clinically important deficiency is more likely to occur (and progress) when intrinsic factor-driven absorption fails than when diet is poor and that most causes take years to produce clinically obvious deficiency. Transient defects have little clinical impact. The key management principle is the importance of follow-up, which also requires knowing how the deficiency arose. The virtues of these principles are not always fully appreciated. Recent developments have made diagnosis and management more difficult by diminishing the ability to determine cobalamin absorption status. Clinicians must also grapple with premature medicalization of isolated, mild biochemical changes that added many asymptomatic cases of still undetermined medical relevance to their caseload, often expanded by inflated cobalamin level criteria. The potential for misattribution of cobalamin-unrelated presentations to nongermane cobalamin and metabolite abnormalities has grown. Pathophysiologically based management requires systematic attention to each of its individual components: correctly diagnosing cobalamin deficiency, reversing it, defining its underlying cause, preventing relapse, managing the underlying disorder and its complications, and educating the patient.
引用
收藏
页码:2214 / 2221
页数:8
相关论文
共 72 条
[41]   NEUROLOGIC ASPECTS OF COBALAMIN DEFICIENCY [J].
HEALTON, EB ;
SAVAGE, DG ;
BRUST, JCM ;
GARRETT, TJ ;
LINDENBAUM, J .
MEDICINE, 1991, 70 (04) :229-245
[42]   Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels [J].
Howard, JM ;
Azen, C ;
Jacobsen, DW ;
Green, R ;
Carmel, R .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1998, 52 (08) :582-587
[43]   CLINICAL TRIAL OF EFFECT OF VITAMIN-B12 IN ELDERLY SUBJECTS WITH LOW SERUM B12 LEVELS [J].
HUGHES, D ;
ELWOOD, PC ;
SHINTON, NK ;
WRIGHTON, RJ .
BRITISH MEDICAL JOURNAL, 1970, 2 (5707) :458-&
[44]   Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency [J].
Hvas, AM ;
Ellegaard, J ;
Nexo, E .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (12) :1534-1541
[45]   NEUROLOGIC AND EVOKED-POTENTIAL ABNORMALITIES IN SUBTLE COBALAMIN DEFICIENCY STATES, INCLUDING DEFICIENCY WITHOUT ANEMIA AND WITH NORMAL ABSORPTION OF FREE COBALAMIN [J].
KARNAZE, DS ;
CARMEL, R .
ARCHIVES OF NEUROLOGY, 1990, 47 (09) :1008-1012
[46]   CLINICALLY SIGNIFICANT VITAMIN-B12 DEFICIENCY SECONDARY TO MALABSORPTION OF PROTEIN-BOUND VITAMIN-B12 [J].
KING, CE ;
LEIBACH, J ;
TOSKES, PP .
DIGESTIVE DISEASES AND SCIENCES, 1979, 24 (05) :397-402
[47]  
Kokkola A, 1998, SCAND J GASTROENTERO, V33, P88
[48]   CYANOCOBALAMIN INJECTIONS FOR PATIENTS WITHOUT DOCUMENTED DEFICIENCY - REASONS FOR ADMINISTRATION AND PATIENT RESPONSES TO PROPOSED DISCONTINUATION [J].
LAWHORNE, L ;
RINGDAHL, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (13) :1920-1923
[49]  
LAWSON DH, 1976, SCAND J HAEMATOL, V17, P347
[50]   PREVALENCE OF COBALAMIN DEFICIENCY IN THE FRAMINGHAM ELDERLY POPULATION [J].
LINDENBAUM, J ;
ROSENBERG, IH ;
WILSON, PWF ;
STABLER, SP ;
ALLEN, RH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 60 (01) :2-11